NCT04149470View on ClinicalTrials.gov

Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 7, 2020

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Eosinophilic Esophagitis
Interventions
DRUG

Omeprazole 20mg BID

High dose PPI therapy (Omeprazole 20mg twice daily)

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
collaborator

Children's Hospital Colorado

OTHER

lead

University of Colorado, Denver

OTHER